SNORA36B: SNORA36B is a snoRNA (small nucleolar RNA) that has been found to be related to clinical stages, histological grade, T classification, lymph node metastasis, and anatomic subdivisions in head and neck squamous cell carcinoma (HNSCC) [PMC10090466]. It has also been identified as a potential biomarker for HNSCC [PMC10090466]. Additionally, sdRNAs derived from SNORA36B have been found to be significantly correlated with the immunosuppressive biomarker PD-L1 in thymoma and lower grade glioma [PMC9149963] [PMC6294694]. SNORA36B is considered a protective factor in HNSCC along with U3 (chr17), while the other snoRNAs mentioned are considered risk factors [PMC7540035]. The functions of SNORA36B include involvement in DNA template regulation [PMC7540035]. However, there are no related reports on the role of SNORA36B in cancer specifically [PMC7540035]. It is worth noting that the proportional hazards assumption was not met for SNORA36B at a BH-adjusted p-value of 0.001 [PMC7483260]. Furthermore, there have been cases where the annotation pipeline favored longer RNA records over shorter ones when two ncRNA genes overlapped in the same region, such as with SNORA36B and hsa-mir-664a [PMC3675212].